Research study investigates impact of therapy dogs for dialysis patients

June 27, 2022

The Dialysis Doggos are part of a research study being conducted by Meredith L. Stensland, PhD, LMSW, assistant professor of research in the Department of Psychiatry and Behavioral Sciences. The study investigates the effect of an animal assisted intervention for patients receiving dialysis, and if this intervention improves symptoms of pain and depression and reduces the number of skipped dialysis treatment sessions.

Dr. Meredith Stensland hugs Gus, a golden-retriever therapy dog.


Novel brain injury treatment tested in 1st human subject

June 17, 2022

An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.

Neuron concept art


NIH awards $2.4 million grant to UT Health San Antonio and ADA Science & Research Institute to study responsible antibiotic use

April 27, 2022

The National Institutes of Health has awarded a four-year, $2.4 million grant to The University of Texas Health Science Center at San Antonio (UT Health San Antonio), which will work in collaboration with the American Dental Association Science & Research Institute (ADASRI) to conduct a clinical trial studying the responsible use of antibiotics in combination with other treatments for periodontal disease, commonly known as gum disease.





Noted cancer researcher receives UT System Faculty STARs award

April 1, 2022

Daohong Zhou, MD, a professor with tenure in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has received a UT System Faculty STARs award in the amount of $1,487,563 to support his drug discovery research.

Star trophy with blue background.